Making salad

(Photo by Unsplash+ in collaboration with Getty Images)

The Protein Craze May Be Backwards, According to a New Science Review

In A Nutshell

  • A new scientific review finds that eating less protein, not more, consistently extends lifespan and improves metabolic health across yeast, fruit flies, and rodents.
  • No study has yet shown that protein restriction extends human lifespan, though short-term human trials show real improvements in blood sugar, insulin sensitivity, and body fat.
  • Just three amino acids, methionine, isoleucine, and valine, appear to drive most of the benefit, meaning cutting total protein may not be necessary.
  • Restriction is not safe for everyone: pregnant women, growing children, and people already underfed could be harmed by eating even less protein.

Americans are loading up on protein like never before, tossing protein bars in their gym bags and protein powder in their coffee. A 2025 report found 61% of American consumers increased protein intake in 2024, up from 48% in 2019. But a sweeping scientific review scheduled for publication in Cell Press Blue makes a case that runs against the grain: eating less protein, not more, may be the better bet for aging well, at least based on the animals studied so far.

In the review, researchers Bailey A. Knopf and Dudley W. Lamming at the University of Wisconsin-Madison mapped out what happens inside the body when protein gets scarce, testing the idea across yeast, fruit flies, rodents, and a handful of early human trials. The picture that emerges cuts against decades of advice telling people, especially older adults, to eat more protein to stay strong.

Higher Protein Intake Is Linked to More Disease and Earlier Death

Current guidelines set the recommended daily allowance for protein at 0.8 grams per kilogram of body weight, with higher amounts often recommended for people over 65 to preserve muscle mass. But large analyses of human dietary data, including NHANES data, have found that higher protein consumption is associated with increased mortality, more diabetes, and greater rates of age-related disease. A 2023 study of British twins found eating more protein was associated with greater rates of sarcopenia, or age-related muscle loss. Those findings do not prove protein caused the problems, and other studies have linked higher protein intake to less frailty, particularly with exercise or plant-based sources.

Clinical trials of reduced-protein diets have shown real health improvements. One trial found people eating a low-protein diet for 43 days lost body weight and fat and had lower fasting blood sugar, despite eating more calories overall. A study in lean men found five weeks of reduced protein improved insulin sensitivity and energy expenditure. Separate research found long-term protein restriction improved outcomes for diabetes-related kidney disease.

Protein sources - meat, fish, cheese, nuts, beans and greens.
Eating less protein, not more, may boost longevity, a new study review finds, though effects on human lifespan remain unknown. (© nadianb – stock.adobe.com)

Protein Restriction Sets Off a Chain Reaction Inside Cells

Knopf and Lamming trace six connected changes that follow when protein drops. It starts with metabolism: restriction consistently burns off body fat and steadies blood sugar, largely through a hormone the body releases when nutrition gets scarce. Mice engineered to make extra of that hormone live noticeably longer. Mice unable to make it at all get no lifespan boost from a low-protein diet, evidence the hormone is doing the heavy lifting.

That shift also flips a switch inside cells. When protein is scarce, the body leans on a stress-response system while quieting a separate growth-signaling pathway that normally tells cells to keep dividing and building. Dialing back that growth signal, across species from flies to mice, has repeatedly been tied to a longer life, nudging the body from build-and-grow mode into repair-and-maintain mode. The same shift appears to clear out more of the worn-out cells that build up in the liver and fat tissue with age and pump out inflammatory signals to their neighbors. Whether it also improves how cells generate energy is shakier: some studies show a benefit, others show none.

Diet may even reach how genes get switched on and off, called epigenetics. Early animal work suggests restricting certain amino acids can shift those genetic switches toward a more youthful pattern, though evidence here is thin, and restriction during pregnancy has sometimes backfired for offspring. Restricted mice also held up better against age-related frailty, even when the diet started later in life. Researchers point to Okinawa, Japan, home to one of the longest-lived populations, whose traditional diet gets only about 9% of calories from protein, though it is also plant-heavy and lower in calories overall, so protein alone cannot take full credit.

A Few Amino Acids Drive Most of Protein Restriction’s Benefits

Cutting total protein turns out not to be strictly necessary. Restricting just methionine, isoleucine, and valine, three of the building blocks that make up protein, appears to reproduce most of the payoff on its own. Isoleucine restriction alone extended mouse lifespan by 33%, and valine restriction added 23% in male mice. Restricting all three together stretched lifespan by 30% in one mouse study and by roughly 65% in fruit flies. In small human trials, cutting this same trio improved insulin sensitivity and blood sugar control, hinting the animal findings may carry over metabolically.

Restriction Can Backfire for Pregnant Women, Children, and Anyone Already Underfed

Protein restriction is not right for everyone. Pregnant women, growing children, people recovering from injury, and those already eating calorie-restricted diets may be harmed by further restriction. Many elderly people are already protein deficient due to reduced appetite or social isolation, and cutting further could push them into real trouble. Exercise offers a partial solution: research cited in the review found exercise can largely offset lean mass loss on low-protein diets.

For now, the honest takeaway is narrower than the protein-bar aisle suggests: what works in mice and flies has not yet been proven to buy people more years, only better metabolic numbers along the way. Anyone tempted to act on this should treat it as a reason to watch protein amounts, not to slash them without a plan.


Disclaimer: This article summarizes findings from a scientific review and is intended for general informational purposes only. It is not medical advice. Anyone considering a change to their protein intake, especially pregnant women, older adults, or people managing a health condition, should talk with a doctor or registered dietitian first.


Paper Notes

Limitations

The authors acknowledge substantial gaps in current knowledge. Most studies on individual amino acids, particularly non-essential ones, have been conducted in lower-order organisms such as yeast and fruit flies, meaning findings may not translate directly to humans. Effects of protein restriction on mitochondrial function have shown inconsistent results across studies. The authors also note that effects can vary based on biological sex and genetic background, and that human data on amino acid restriction is still preliminary. Long-term, well-powered randomized controlled trials in humans are largely absent. Whether the lifespan-extending effects observed in animals will translate to meaningful increases in human lifespan remains unknown.

Funding and Disclosures

According to the paper, the Lamming lab receives support in part from the National Institute on Aging through multiple grants (AG056771, AG062328, AG081482, AG084156, AG085898, and AG094153), as well as from the Wisconsin Partnership Program and startup funds from the University of Wisconsin-Madison. Dudley W. Lamming is a member of the Wisconsin Nathan Shock Center of Excellence in the Basic Biology of Aging (P30 AG092586). Work was supported using facilities and resources from the William S. Middleton Memorial Veterans Hospital. The authors note that the content does not necessarily represent the official views of the NIH and does not represent the views of the Department of Veterans Affairs or the United States government. Dudley W. Lamming discloses that he has received funding from and serves as a scientific advisory board member of Aeovian Pharmaceuticals, a company that seeks to develop mTOR inhibitors for disease treatment.

Publication Details

Authors: Bailey A. Knopf and Dudley W. Lamming, both affiliated with the Department of Medicine, University of Wisconsin-Madison; the William S. Middleton Memorial Veterans Hospital; and the Cell and Molecular Biology Graduate Program, University of Wisconsin-Madison. Dudley W. Lamming is also affiliated with the University of Wisconsin Comprehensive Diabetes Center and the Wisconsin Nathan Shock Center of Excellence in the Basic Biology of Aging. | Paper Title: “The hallmarks of protein and amino acid restriction in aging and longevity” | Journal: Cell Press Blue | Publication Date: August 17, 2026 (scheduled) | DOI: https://doi.org/10.1016/j.cpblue.2026.100079


About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor

Leave a Comment